Vaccine composition for prevention or treatment of SARS-coronavirus-2 infection

The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit of a spike protein of SARS-coronavirus-2 and a polypeptide constituting a tetanus toxin (TT) epitope P2 domain, and a vaccine composition comp...

Full description

Saved in:
Bibliographic Details
Main Authors Seo, Ki-weon, Lee, Yoonjae, Kim, Chi-Yong, Hong, Seung-hye, Kim, Eun-som, Kwon, Teawoo
Format Patent
LanguageEnglish
Published 03.09.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit of a spike protein of SARS-coronavirus-2 and a polypeptide constituting a tetanus toxin (TT) epitope P2 domain, and a vaccine composition comprising the same.
AbstractList The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit of a spike protein of SARS-coronavirus-2 and a polypeptide constituting a tetanus toxin (TT) epitope P2 domain, and a vaccine composition comprising the same.
Author Kim, Eun-som
Hong, Seung-hye
Lee, Yoonjae
Seo, Ki-weon
Kim, Chi-Yong
Kwon, Teawoo
Author_xml – fullname: Seo, Ki-weon
– fullname: Lee, Yoonjae
– fullname: Kim, Chi-Yong
– fullname: Hong, Seung-hye
– fullname: Kim, Eun-som
– fullname: Kwon, Teawoo
BookMark eNqNyj0KAjEQQOEUWvh3h_EAAU1gxVJFsROM2i5hmEDAnQlJ3PO7igewenzwpmrEwjRRl4dHjEyA0iUpsUZhCJIhZeqJvxxUM_naDQYJ4HZXp1GysO9jfhVtIHIg_MxzNQ7-WWjx60wtT8fb4awpSUsleSSm2t7d2qw2jd3avbH_PG-d4jjt
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US12076393B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US12076393B23
IEDL.DBID EVB
IngestDate Fri Sep 20 10:08:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US12076393B23
Notes Application Number: US202118034141
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240903&DB=EPODOC&CC=US&NR=12076393B2
ParticipantIDs epo_espacenet_US12076393B2
PublicationCentury 2000
PublicationDate 20240903
PublicationDateYYYYMMDD 2024-09-03
PublicationDate_xml – month: 09
  year: 2024
  text: 20240903
  day: 03
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies SK BIOSCIENCE CO., LTD
RelatedCompanies_xml – name: SK BIOSCIENCE CO., LTD
Score 3.569244
Snippet The present invention provides a recombinant antigen protein for preventing SARS-coronavirus-2 infection, comprising a polypeptide derived from an S1 subunit...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Vaccine composition for prevention or treatment of SARS-coronavirus-2 infection
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240903&DB=EPODOC&locale=&CC=US&NR=12076393B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKupNq6J1YQTJbTBbm-QQxGahCG1K05TeSjKZQHtIS5Pq3_dNSFovepsFHjMP3jbzzTcAr5nOYz3NDMoMg1Hd5AlNYovRDKM55yZL5UQUiqNxfxjpn4veogXr5i1MxRP6XZEjokUxtPey8tfb4yGWW2Eri7dkhUObd39mu1JdHWN4smRNcge2NwncwJEcx45CaTy1FRULds3SBuiuT0QaLXj2vflAvErZ_g4p_iWcTlBaXl5Bi-cdOHean9c6cDaqL7yxWdtecQ3BPGZikAgUeA21Iphykm3NwoRd7B2Q42STkfBjGlImSArir9VuX1CVNOir_AZefG_mDCmubHlQwzIKj5vQbqGdb3J-B4QbnPVThclckJFhQqFkKk8z1lOZGadxcg_dv-V0_5t8gAuh0gpRpT1Cu9zt-ROG4DJ5rnT3A7APjgY
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD4haMQ3RY3grSZmb42wDbY9LEY2CCq3sEF4I1vXJfgwFjb073vaDPBF33pJmvYkp6df-52vAE-xzgM9ig3KDINR3eQhDQOL0RijOecmixqhAIrDUbs_098XrUUJPne5MFIn9FuKI6JHMfT3XO7X6eESy5Xcyuw5XGHT-qXn265SoGMMT1ZDU9yO3Z2M3bGjOI4985TR1G6qCNg1S-vgdn1kICSUUGneEVkp6e-Q0juD4wmOluTnUOJJFSrO7ue1KpwMiwdvLBa-l13AeB4w0UgEC7ygWhE8cpK0UGHCKtb2zHGyjon3OvUoEyIFwddqs82oSnbsq-QSHntd3-lTnNlyb4blzDssQruCcrJO-DUQbnDWjpqswYUYGR4omrHKo5i1VGYGURDWoP73OPX_Oh-g0veHg-XgbfRxA6fCvJJdpd1COd9s-R2G4zy8l3b8AXlskPA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Vaccine+composition+for+prevention+or+treatment+of+SARS-coronavirus-2+infection&rft.inventor=Seo%2C+Ki-weon&rft.inventor=Lee%2C+Yoonjae&rft.inventor=Kim%2C+Chi-Yong&rft.inventor=Hong%2C+Seung-hye&rft.inventor=Kim%2C+Eun-som&rft.inventor=Kwon%2C+Teawoo&rft.date=2024-09-03&rft.externalDBID=B2&rft.externalDocID=US12076393B2